Jaringan Laboratorium Medis

Vol. 4 No. 2 (2022): November 2022
Original Articles

Profile of Sputum Examination Results in Multidrug-Resistant Tuberculosis (MDR-TB) Patients

PDF
  • Alisa Khodrun Nadza,
  • Surati
Alisa Khodrun Nadza
Poltekkes Kemenkes Semarang
Surati
Poltekkes Kemenkes Semarang

Published 2023-12-07

Keywords

  • Sputum Examination Results,
  • BTA,
  • MDR-TB

Copyright (c) 2022 Jaringan Laboratorium Medis

Creative Commons License

This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.

How to Cite

Profile of Sputum Examination Results in Multidrug-Resistant Tuberculosis (MDR-TB) Patients. (2023). Jaringan Laboratorium Medis, 4(2), 86-90. https://doi.org/10.31983/jlm.v4i2.8526

CrossMark



Dimensions

If it doesn't Appear, click here



PlumX Metrics



Impact Factor

or, Visit on here

Abstract

TB patients who do not adhere to OAT treatment can lead to resistance and become MDR-TB and add to the burden of TB management globally. TB control programs including microscopic sputum examination are important for diagnosis, evaluation, follow-up treatment, and follow-up. The results of the sputum examination used the IUATLD scale as an interpretation of the results and the reporting was negative, scanty, positive one, positive two, and positive three according to the number of TB germs found. The results of the sputum examination to determine the classification of the patient, the decision to start treatment, and the patient's recovery. At the step of treatment for MDR-TB patients, the results of sputum examination are an indicator to determine the success rate of treatment which is marked by the conversion of BTA. Research objectives is to determine the description of the results of sputum examination in Multidrug-Resistant Tuberculosis (MDR-TB) patients at the Kendal District Health Center. Research methods is observational research with descriptive research criteria through a cross sectional approach. Respondents of the study were multidrug-resistant tuberculosis (MDR-TB) patients from three health centers in Kendal district with the highest case prevalence. The study respondents were 7 MDR-TB patients. All study respondents, totaling 7 MDR-TB patients (100%), were included in the advanced step of treatment and showed negative sputum examination results. All study respondents (100%) showed that the results of microscopic sputum examination were negative, which means that BTA conversion occurred at the advanced treatment step.

PDF

Downloads

Download data is not yet available.

References

  1. Azmi, A. S. (2013). Prevalesi Risiko Tuberkulosis Multi Drug Resistance ( TB-MDR ) di Kota Depok Tahun 2010 - 2012. Skripsi.
  2. Dinas Kesehatan Kendal. (2020).
  3. Jan, F. (2018). Haematological And Biochemical Parameters In Multi Drug Resistant Tuberculosis By Haematological And Biochemical Parameters In Multi Drug Resistant Tuberculosis.
  4. Kalma. (2016). Studi Hasil Pemeriksaan Serum Glutamic Oxalacetic Transaminase Dan Serum Glutamic Phyruvic Transaminase Pada Penderita Tuberkulosis Paru Sebelum Dan Setelah Satu Bulan Mengkonsumsi Obat Anti Tuberkulosis. VII(2), 7–18.
  5. Kasih, K. N., & Sulastina, N. A. (2019). Analisis Laju Endap Darah Pada Pasien Tuberkulosis Paru. Jurnal ’Aisyiyah Medika, 4(1), 44–52. https://doi.org/10.36729/jam.v4i1.232
  6. Kementerian Kesehatan RI. (2015). profil-kesehatan-Indonesia-2015.
  7. Kementerian Kesehatan RI. (2017). PMK NOMOR 67 TAHUN 2016 Tentang Penanggulangan Tuberkulosis. Dinas Kesehatan, 163.
  8. Nelma, N., & Lumbantoruan, A. (2019). Pengaruh Penundaan Penanganan Sputum Terhadap Hasil Pembacaan Sediaan Secara Mikroskopis Pada Penderita TB di UPT. Laboratorium Kesehatan Daerah Provinsi Sumatera Utara. Jurnal Ilmiah PANNMED (Pharmacist, Analyst, Nurse, Nutrition, Midwivery, Environment, Dentist), 14(1), 95–100. https://doi.org/10.36911/pannmed.v14i1.570
  9. Saputri, I. N., & Munthe, E. L. (2020). Tuberkulosis Resisten Ganda (TB-MDR) dan Implementasi Upaya Pengendalian di Kabupaten Ketapang. Jurnal Respirologi Indonesia, 40(1).
  10. Wahyuni, V. K., Agustina, M., Tri, E., & Novitasari, D. (2020). Tuberkulosis Paru Dengan Strategi Directly Observed Treatment Shortcourse. 4(1), 37–42.
  11. WHO. (2020). Global TB Report.
  12. WHO, (2019). Tuberculosis surveillance and monitoring in Europe. 华创证券, 2,19.